A major breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial malignant suppressor protein is frequently inactivated in various forms of cancer, resulting https://bookmarklinkz.com/story21859052/vhh-fragments-reactivate-the-p53-protein-the-potential-pathway-for-cancer-management